Dr. Harry S. Ojeas, MD

Dr. Ojeas practices at Texas Digestive Disease Consultants in Pasadena, Texas.

Dr. Ojeas' NPI, 1528051042, was assigned on August 30, 2005. Dr. Ojeas graduated from University of Puerto Rico, Medical Sciences Campus in 1990. Dr. Ojeas holds Texas license J1472.

Dr. Ojeas' primary practice is Texas Digestive Disease Consultants, at 4211 Fairmont Pkwy, Pasadena, TX 77504 in Harris County. The practice phone is (832) 255-5681.

Dr. Ojeas' primary practice is Texas Digestive Disease Consultants in Pasadena, Texas. Dr. Ojeas is also affiliated with HCA Houston Healthcare Southeast. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Dr. Ojeas to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ojeas practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ojeas' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ojeas is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Ojeas' licenses on file in 2 states: Texas and Oklahoma.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and hepatitis c among the conditions Dr. Ojeas treats.

CMS data shows 599 Medicare services from Dr. Ojeas across 15 procedure codes in 2024, for 294 Medicare patients. Medicare paid $58,615 for them.

CMS counts 294 Medicare patients who saw Dr. Ojeas in 2024. The largest group is 65 to 74, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ojeas' median patient age at 67, with 55% women.

In 2024, Dr. Ojeas wrote 3,500 Medicare Part D claims for 1,318 patients. 70% of them were for generic drugs. CMS names the drug for 3,328 of them, across 34 drugs with 11 or more claims each, at $589,279 in total drug cost. In 2023, CMS named 3,281 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Ojeas for performance year 2024, reported as part of a group. Dr. Ojeas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 138 procedures of colonoscopy by Dr. Ojeas, more than 87% of the clinicians it reports for that procedure.

Dmand AI links Dr. Ojeas to 2 clinical trials. Conditions studied include Colonic Polyps, Rectal Diseases and Colorectal Neoplasms.

CMS Open Payments shows 1,373 general payments to Dr. Ojeas from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $5,015.

Dr. Ojeas graduated from University of Puerto Rico, Medical Sciences Campus in 1990.

Dr. Ojeas is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.